Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott.

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...

Senseonics (NYSE:SENS) announced today that it commenced an underwritten public offering of common stock worth $50 million.

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...

Insulet recorded a 31.3% bottom-line slide on a sales increase of 28.8%. Adjusted to exclude one-time items, earnings per ...